Control of irritable bowel syndrome with polyamine analogs: a structure-activity study

Area of Science:

• Pharmacology
• Gastroenterology
• Medicinal Chemistry

Background:

• Diarrhea-predominant irritable bowel syndrome (IBS-D) poses a significant health challenge.
• Current treatments for IBS-D have limitations, necessitating novel therapeutic approaches.

Purpose of the Study:

• To evaluate polyamine analogs as potential agents for ameliorating IBS-D symptoms.
• To identify key structural determinants of activity within polyamine analogs.

Main Methods:

• Compounds were administered subcutaneously in a rodent model of stress-induced IBS-D.
• Efficacy was assessed by the dose-dependent reduction in stool output.
• Selected compounds were further evaluated for oral efficacy.

Main Results:

• The spermine pharmacophore serves as a valuable scaffold for developing IBS-D therapeutics.
• Compound activity is sensitive to terminal alkyl groups and methylene spacer geometry.
• N,N'-bis[3-(ethylamino)propyl]-trans-1,4-cyclohexanediamine demonstrated significant oral efficacy.

Conclusions:

• Polyamine analogs, particularly those based on the spermine structure, show potential for treating IBS-D.
• Structural modifications significantly impact the therapeutic activity of these compounds.
• Further exploration of this pharmacophore is warranted for developing new IBS-D treatments.